Point72 Hong Kong’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,857
Closed -$57.4K 540
2025
Q2
$57.4K Buy
2,857
+314
+12% +$6.04K ﹤0.01% 366
2025
Q1
$46.1K Buy
2,543
+2,517
+9,681% +$45.1K ﹤0.01% 380
2024
Q4
$458 Buy
+26
New +$499 ﹤0.01% 379
2022
Q4
Sell
-20,351
Closed -$236K 851
2022
Q3
$236K Buy
20,351
+20,256
+21,322% +$278K 0.01% 1002
2022
Q2
$1K Sell
95
-3,847
-98% -$63K ﹤0.01% 1814
2022
Q1
$76K Buy
+3,942
New +$70.4K ﹤0.01% 1223
2019
Q4
Sell
-216
Closed -$2K 1289
2019
Q3
$2K Buy
216
+111
+106% +$1.33K ﹤0.01% 869
2019
Q2
$2K Buy
105
+34
+48% +$482 ﹤0.01% 997
2019
Q1
$1K Buy
+71
New +$1.15K ﹤0.01% 945
2017
Q3
Sell
-49
Closed -$1K 914
2017
Q2
$1K Buy
+49
New +$615 ﹤0.01% 714

Other funds holding INVA

Point72 Hong Kong's INVA Position: Q3 2025 in Review

Point72 Hong Kong sold out of Innoviva (INVA) in Q3 2025, closing a stake of 2,857 shares — an estimated $57.4K sold.

Point72 Hong Kong first reported a position in INVA in Q2 2017 and held it in 10 quarters. The position peaked at $236K in Q3 2022. 264 funds tracked by Wall St. Rank hold INVA as of Q3 2025.

  • Point72 Hong Kong reported no remaining Innoviva position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 2,857 Innoviva shares in Q3 2025, an estimated $57.4K.
  • Point72 Hong Kong first reported a position in Innoviva in Q2 2017 and held it in 10 quarters.
  • Point72 Hong Kong's Innoviva position peaked at $236K in Q3 2022.
  • 264 funds tracked by Wall St. Rank held Innoviva as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.